IL18 and in situ carcinoma: QUE-loaded chitosan nanoparticles were used to reduce IL-18 and KIM-1 levels in renal tissues of CIS-intoxicated rats and improved histological changes such as renal interstitial nephritis, glomerular atrophy, tubular dilatation, cell degeneration, and necrosis caused by CIS (104).